Sangam Health Care Products Limited has submitted a formal intimation to BSE Limited regarding an upcoming meeting of its Board of Directors. The meeting is scheduled to be held on Thursday, August 13, 2026, at the company's registered office.
The primary agenda items for the board meeting include:
- Consideration and approval of the un-audited financial results for the quarter ended June 30, 2026 (Q1 FY27)
- Review of the Limited Review Report for the quarter ended June 30, 2026
- Any other business matters with the permission of the Chair
This disclosure is made in compliance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has requested that this information be placed on record with the exchange.
Financial Impact
Financial results for the quarter are pending board approval. Impact will be determined after the board meeting on August 13, 2026.